Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
Clinical trial NCT03071263 · COMPLETED
Trial details
- NCT number
- NCT03071263
- Sponsor
- Relypsa, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-23
- Primary completion
- 2018-11-27
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.